Zhou Zhu

Nanjing University of Chinese Medicine — China

Medicine · Health Sciences

39h-index11.8kcitations122works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autophagy in Disease and Therapy(18), Cancer-related Molecular Pathways(17), Advanced Breast Cancer Therapies(17), Alzheimer's disease research and treatments(14), Cancer Genomics and Diagnostics(11)

Publications120 total

Retraction notice to "SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway" [Heliyon 10 (2024) e24394]
Heliyon·2025Open Access
Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS‐Mediated Autophagy by Direct Targeting of Antioxidant Enzymes PRDX1 and PRDX2
Advanced Biology·2025
LBA70 Association of radiomic features ± on-treatment ctDNA detection with treatment outcomes in patients with resectable NSCLC: Exploratory analyses from AEGEAN
Annals of Oncology·2025
Targeting ADAM17 N-glycosylation Enhances Radiosensitivity in Non-Small Cell Lung Cancer via the NOTCH-ABCC1-ROS/cGAMP axis
International Journal of Radiation Oncology*Biology*Physics·2025
Histone H3 lysine 18 lactylation attenuates neuroinflammation and neurological damage by regulating microglial plxnb2 after ischemic stroke
Neurobiology of Disease·2025· 2 citedOpen Access
Clinical-oriented 3D visualization and quantitative analysis of gingival thickness using convolutional neural networks and CBCT
Frontiers in Dental Medicine·2025Open Access
Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a national cohort of middle-aged and older Chinese adults
Frontiers in Endocrinology·2025· 3 citedOpen Access
TREK-1 in central nervous system diseases
Chinese Medical Journal·2025Open Access
Licochalcone A selectively modulates mTORC1‐TFEB to enhance autophagy and demonstrates neuroprotective effects in a mouse model of Parkinson's disease
Brain‐X·2025Open Access
Association of post-surgical MRD status with neoadjuvant ctDNA dynamics, genomic mutations, and clinical outcomes in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial.
Journal of Clinical Oncology·2025· 4 cited
Computational analysis of DEHP’s oncogenic role in colorectal cancer
Discover Oncology·2025· 2 citedOpen Access
TREK- 1 Ameliorates Secondary Brain Injury by Regulating Inflammatory Microenvironment via CX3 CL1-CX3 CR1 Pathway After Intracerebral Hemorrhage
Molecular Neurobiology·2025· 1 cited
The rheumatoid arthritis drug Auranofin targets peroxiredoxin 1 and peroxiredoxin 2 to trigger ROS-endoplasmic reticulum stress axis-mediated cell death and cytoprotective autophagy
Free Radical Biology and Medicine·2025· 10 cited
Circular RNA ARF3 attenuates PM2.5-induced inflammatory response in human bronchial epithelial cells by regulating microRNA-509-3p and chromodomain helicase DNA binding protein 9
ScienceAsia·2025Open Access
Residual strength of Al2O3 reinforced Sc2O3-Y2O3-ZrO2 ceramics and fractal characterization of their crack patterns after quenching
SSRN Electronic Journal·2025Open Access
Application of mixed reality bone registration and positioning technology in orthognathic surgery
International Journal of Oral and Maxillofacial Surgery·2024· 6 cited
Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms
Journal of Neuroinflammation·2024· 41 citedOpen Access
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
npj Precision Oncology·2024· 7 citedOpen Access
LBA49 Associations of ctDNA clearance (CL) during neoadjuvant Tx with pathological response and event-free survival (EFS) in pts with resectable NSCLC (R-NSCLC): Expanded analyses from AEGEAN
Annals of Oncology·2024· 21 citedOpen Access
436TiP DYNASTY-Breast02: A phase III trial of BNT323/DB-1303 vs investigator's choice chemotherapy in HER2-low, hormone receptor positive, metastatic breast cancer
Annals of Oncology·2024· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Ashok Iyaswamy(17), Sravan Gopalkrishnashetty Sreenivasmurthy(17), Ju‐Xian Song(16), Jia Liu(14), King‐Ho Cheung(14), Min Li(14), Cheng-Fu Su(13), Benjamin Chun‐Kit Tong(12), Jiahong Lu(12), Senthilkumar Krishnamoorthi(9), Chuanbin Yang(7), Ziying Wang(7), Jieqiong Tan(7), Xinjie Guan(7), Sandeep Malampati(6), Siva Sundara Kumar Durairajan(6), George M. Church(4), Yuxuan Kan(4), Annie Yang(3), Frank McKeon(3)